Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
BAXTER INTERNATIONAL INC. et al v. UNITED STATES FOOD AND DRUG ADMINISTRATION
Case Number:
1:13-mc-00672
Court:
Nature of Suit:
Judge:
Companies
Government Agencies
Sectors & Industries:
-
October 07, 2013
CSL To Pay $64M To Escape Blood Plasma Antitrust Suit
Australian medical product giant CSL Ltd. announced Monday that it will pay $64 million to escape a consolidated antitrust class action in which hospital groups claim it took part in a conspiracy to artificially hike the price of plasma-derivative protein therapies.
-
September 16, 2013
Baxter Wins Bid To Compel FDA Testimony In Plasma MDL
Baxter International Inc. won a bid to get a Food and Drug Administration official to testify in multidistrict litigation in which a class of hospitals allege the company and other plasma therapy providers conspired to fix prices, according to an order in D.C. federal court Monday.